PCA
CELG

Providence Capital Advisors’s Celgene Corp CELG Stock Holding History

Providence Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-27,575
Closed -$1.77M – 346
2018
Q4 		$1.77M Buy
27,575
+1,018
+4% +$75.1K 1.21% 38
2018
Q3 		$2.38M Buy
26,557
+933
+4% +$82.5K 1.55% 15
2018
Q2 		$2.04M Buy
25,624
+8,090
+46% +$672K 1.43% 23
2018
Q1 		$1.56M Buy
17,534
+1,138
+7% +$109K 1.17% 38
2017
Q4 		$1.71M Buy
+16,396
New +$1.85M 1.32% 30

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Providence Capital Advisors's CELG Position: Q1 2019 in Review

Providence Capital Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 27,575 shares — an estimated $1.77M sold.

Providence Capital Advisors first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $2.38M in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Providence Capital Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Providence Capital Advisors sold 27,575 Celgene Corp shares in Q1 2019, an estimated $1.77M.
  • Providence Capital Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
  • Providence Capital Advisors's Celgene Corp position peaked at $2.38M in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Providence Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.